Compare GHI & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Current Price
| Metric | GHI | STIM |
|---|---|---|
| Founded | 1998 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.3M | 115.5M |
| IPO Year | 1998 | 2018 |
| Metric | GHI | STIM |
|---|---|---|
| Price | $5.21 | $1.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $10.50 | $3.00 |
| AVG Volume (30 Days) | 66.2K | ★ 1.4M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | ★ 22.93% | N/A |
| EPS Growth | N/A | ★ 57.25 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $85,389,766.00 | $52,776,000.00 |
| Revenue This Year | $273.95 | $11.10 |
| Revenue Next Year | N/A | $11.92 |
| P/E Ratio | $527.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.71 | $0.80 |
| 52 Week High | $11.45 | $4.84 |
| Indicator | GHI | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 41.26 | 55.74 |
| Support Level | $5.05 | $1.21 |
| Resistance Level | $5.52 | $1.75 |
| Average True Range (ATR) | 0.18 | 0.20 |
| MACD | -0.07 | 0.03 |
| Stochastic Oscillator | 8.25 | 32.86 |
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.